Synthesis and Characterization of ULK1/2 Kinase Inhibitors that Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung Cancer
Fabiana Izidro Layng(Discovery Institute), Nicholas D. P. Cosford(Discovery Institute)
Cited by 1
Related Papers
ULK1/2 Inhibitors that Degrade ATG13 Effectively Target KRAS-Mutant Cancers
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0